WO2009028867A3 - Bacteria lysates prepared by bacteriolytic lysin enzyme, and vaccine composition for preventing animal disease comprising the same - Google Patents
Bacteria lysates prepared by bacteriolytic lysin enzyme, and vaccine composition for preventing animal disease comprising the same Download PDFInfo
- Publication number
- WO2009028867A3 WO2009028867A3 PCT/KR2008/005020 KR2008005020W WO2009028867A3 WO 2009028867 A3 WO2009028867 A3 WO 2009028867A3 KR 2008005020 W KR2008005020 W KR 2008005020W WO 2009028867 A3 WO2009028867 A3 WO 2009028867A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vaccine
- bacteriolytic
- vaccine composition
- bacteria
- lysin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
Abstract
The present invention relates to a vaccine composition for preventing infectious animal diseases caused by bacteria, more precisely a vaccine composition for preventing infectious animal diseases containing the bacterial lysate prepared by lysin, the bacteriophage-originated bacteriolytic protein, capable of destroying specifically peptidoglycan structure of bacterial cell wall. The bacterial lysate prepared by lysin, the bacteriophage-originated bacteriolytic protein, is not converted into a toxic strain, so that it is safer than the conventional live vaccine or attenuated live vaccine and has live vaccine like immunogenicity inducing immune response. Thus, the bacterial lysate of the present invention can be used as a composition having excellent protect ivity against bacterial infection and thereby further applied in a vaccine or a feed additive for preventing infectious animal diseases caused by bacteria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070086020A KR100974185B1 (en) | 2007-08-27 | 2007-08-27 | Bacteria lysates prepared by bacteriolytic lysin enzyme, and vaccine composition for preventing animal disease comprising the same |
KR10-2007-0086020 | 2007-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009028867A2 WO2009028867A2 (en) | 2009-03-05 |
WO2009028867A3 true WO2009028867A3 (en) | 2009-04-23 |
Family
ID=40388012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2008/005020 WO2009028867A2 (en) | 2007-08-27 | 2008-08-27 | Bacteria lysates prepared by bacteriolytic lysin enzyme, and vaccine composition for preventing animal disease comprising the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100974185B1 (en) |
WO (1) | WO2009028867A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101381798B1 (en) | 2013-02-27 | 2014-04-07 | 씨제이제일제당 (주) | Novel bacteriophage and antibacterial composition comprising the same |
KR101381795B1 (en) | 2013-02-27 | 2014-04-07 | 씨제이제일제당 (주) | Novel bacteriophage and antibacterial composition comprising the same |
KR101381793B1 (en) | 2013-02-27 | 2014-04-07 | 씨제이제일제당 (주) | Novel bacteriophage and antibacterial composition comprising the same |
KR101381797B1 (en) | 2013-02-27 | 2014-04-07 | 씨제이제일제당 (주) | Novel bacteriophage and antibacterial composition comprising the same |
KR101381796B1 (en) | 2013-02-27 | 2014-04-25 | 씨제이제일제당 (주) | Novel bacteriophage and antibacterial composition comprising the same |
KR101590108B1 (en) | 2014-04-10 | 2016-01-29 | 씨제이제일제당(주) | Novel bacteriophage and composition comprising the same |
KR101980146B1 (en) * | 2016-08-31 | 2019-05-20 | 대한민국(관리청: 특허청장, 승계청: 환경부 국립생물자원관장) | Mastoparan Peptide for Manufacturing Inactivated Non Living Vaccine and Non Living Vaccine Using the Same |
CN114028550A (en) * | 2021-11-15 | 2022-02-11 | 苏州大学 | Vaccine system for preventing or treating diseases based on one or more bacterial whole cell components and preparation method and application thereof |
CZ2022297A3 (en) * | 2022-07-01 | 2024-02-21 | FAGOFARMA s.r.o. | Carbomer hydrogel for maintaining natural skin microbiota and reducing pathogenic bacteria |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0510907A2 (en) * | 1991-04-20 | 1992-10-28 | Agricultural And Food Research Council | Bacteriophage lysins and their applications in destroying and testing for bacteria |
WO1996007756A1 (en) * | 1994-09-09 | 1996-03-14 | Jsd Technologies, Ltd. | Decomposition of bacteria cells by phage lysins |
KR20020043585A (en) * | 1999-09-14 | 2002-06-10 | 뉴 호라이즌스 다이아그노스틱스, 인코포레이티드 | The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
-
2007
- 2007-08-27 KR KR1020070086020A patent/KR100974185B1/en active IP Right Grant
-
2008
- 2008-08-27 WO PCT/KR2008/005020 patent/WO2009028867A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0510907A2 (en) * | 1991-04-20 | 1992-10-28 | Agricultural And Food Research Council | Bacteriophage lysins and their applications in destroying and testing for bacteria |
WO1996007756A1 (en) * | 1994-09-09 | 1996-03-14 | Jsd Technologies, Ltd. | Decomposition of bacteria cells by phage lysins |
KR20020043585A (en) * | 1999-09-14 | 2002-06-10 | 뉴 호라이즌스 다이아그노스틱스, 인코포레이티드 | The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
Non-Patent Citations (7)
Title |
---|
DATABASE GENBANK 24 December 2006 (2006-12-24), "endolysin [Staphylococcus phage K]", retrieved from http://www.ncbi.nlm.nih.gov/entrezJviewer.fcgi?dbrotein&id=119658102 Database accession no. ABL87139 * |
DATABASE GENBANK 30 March 2006 (2006-03-30), "putative lysin [Staphylococcus phage K]", retrieved from http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?48696421:NCBI:13132968 Database accession no. YP 024461 * |
DATABASE GENBANK 6 May 2004 (2004-05-06), "ORF30/ORF32 [Staphylococcus phage K]", retrieved from http://www.ncbi.nlm.nih.gov/entrezJviewer.fcgi?dbrotein&id=47060310 Database accession no. AA047477 * |
MARTIN J. LOESSNER ET AL.: "A new procedure for efficient recovery of DNA, RNA, and proteins from Listeria cells by rapid lysis with a recombinant Bacteriophage endolysin.", APPLIED AND ENVIRONMENTAL MICROBIOLOGY., vol. 61, no. 3, March 1995 (1995-03-01), pages 1150 - 1152 * |
MARTIN J. LOESSNER.: "'Bacteriophage endolysins-current state of research and applications.' In", CURRENT OPINION IN MICROBIOLOGY., vol. 8, no. 4, August 2005 (2005-08-01), pages 480 - 487 * |
S. O'FLAHERTY ET AL.: "Genome of Staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content.", JOURNAL OF BACTERIOLOGY., vol. 186, no. 9, May 2004 (2004-05-01), pages 2862 - 2871 * |
VIVEK JAIN ET AL.: "Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae and Salmonella enterica serovar Typhimurium-based DNA vaccine delivery system.", INFECTION AND IMMUNITY., vol. 68, no. 2, February 2000 (2000-02-01), pages 986 - 989 * |
Also Published As
Publication number | Publication date |
---|---|
KR100974185B1 (en) | 2010-08-05 |
WO2009028867A2 (en) | 2009-03-05 |
KR20090021475A (en) | 2009-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009028867A3 (en) | Bacteria lysates prepared by bacteriolytic lysin enzyme, and vaccine composition for preventing animal disease comprising the same | |
Rodríguez-Rubio et al. | Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics | |
Carvalho et al. | Bacteriophages and their derivatives for the treatment and control of food-producing animal infections | |
WO2008039408A3 (en) | Live bacterial vaccines for viral infection prophylaxis or treatment | |
WO2007022425A3 (en) | Influenza recombinant subunit vaccine | |
PL1954308T3 (en) | Stabilizers for freeze-dried vaccines | |
JP2010503399A5 (en) | ||
WO2007092792A3 (en) | Yeast-based vaccine for inducing an immune response | |
MX2009006178A (en) | Salmonella vaccine. | |
WO2010036938A3 (en) | Nanoemulsion therapeutic compositions and methods of using the same | |
WO2008012538A3 (en) | Live vaccine strains of francisella | |
WO2009082647A3 (en) | Recombinant rift valley fever (rvf) viruses and methods of use | |
GB2458057A (en) | Francisella strain for live vaccine | |
WO2016205641A3 (en) | Respiratory syncytial virus having cleavage-resistant g protein and related materials and methods | |
WO2006078975A3 (en) | Improved vaccine against feline calicivirus | |
WO2009008924A3 (en) | Methods of preventing and treating viral infections by inhibiting the deisgylation activity of otu domain-containing viral proteins | |
WO2009105192A3 (en) | Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax | |
PH12014501688A1 (en) | Influenza c virus and vaccine | |
WO2007120309A3 (en) | Attenuated brucella melitensis mutants | |
WO2004082596A3 (en) | Yersinia species compositions | |
WO2003049670A3 (en) | Adjuvant formulations for bacterial and virus vaccines and method of making same | |
WO2019097550A3 (en) | Herbal composition for treatment and management of infectious diseases and method of preparation thereof | |
EP1074266A3 (en) | Live attenuated bacteria for use in a vaccine | |
WO2005021031A3 (en) | Live attenuated bacterial vaccine | |
Cengiz et al. | Detección de infecciones por Sphingomonas paucimobilis en animales domésticos por VITEK Compaq® 2 y PCR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08793524 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08793524 Country of ref document: EP Kind code of ref document: A2 |